Printer Friendly
The Free Library
14,496,463 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Seikagaku Obtains Sales Distribution Approval for MukoUp.


Tokyo, Japan, Oct 20, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Seikagaku Corporation today announced that it has obtained sales distribution approval for MukoUp, a type of medical equipment used in endoscopic en·do·scope  
n.
An instrument for examining visually the interior of a bodily canal or a hollow organ such as the colon, bladder, or stomach.



en
 mucosal resection, from the Ministry of Health, Labor and Welfare.

MukoUp has superior viscoelasticity Viscoelasticity, also known as anelasticity, is the study of materials that exhibit both viscous and elastic characteristics when undergoing deformation. Viscous materials, like honey, resist shear flow and strain linearly with time when a stress is applied.  and is considered to be very safe. It is inserted beneath the membrane and retains membrane protuberance protuberance /pro·tu·ber·ance/ (-too´ber-ans) a projecting part, or prominence.

mental protuberance
 for long periods of time during endoscopic mucosal resection operations.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Oct 20, 2006
Words:78
Previous Article:Sumitomo Metals Develops Technology for Evaluating Crash Performance of Components and Systems.
Next Article:Morinaga Milk Announces Research Results of Lactoferrin on Peridontal Disease.



Related Articles
FAULDING TO MARKET ENALAPRILAT INJECTION/ENALAPRIL TABLETS.
Altered Production Process for Japan.
IDEC Pharmaceuticals Announces Extension of Its Collaborative Agreement With Seikagaku Corporation for IDEC-152 In Allergic Asthma and Other Allergic...
Morinaga Gets Its Upgraded Food Allergen Detection Kit Designated by Government.
Seikagaku, Discovery Partners International Identify Drug Compound Candidates That Target Sugar Chain Enzymes.
Seikagaku to Boost ARTZ Dispo Production Capacity.
AnGes MG, Seikagaku to Dissolve Joint Development Agreement for NFkB Decoy-Oligo-based Intraarticular Injection.
Seikagaku to Begin Clinical Trials of Injectable Hyaluronic Acid Gel for Knee Osteoarthritis Treatment in US.
Can-Fite Out Licenses Rights for its Drug, CF101, in Japan to the Seikagaku Corporation and Expects to Receive US$ 19.5 Million from Licensing Fees...
Can-Fite to Commence Phase II Clinical Trials to Investigate the Efficacy of CF101 in the Treatment of Psoriasis.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles